Vernalis' Frova: Mixed Blessing
Executive Summary
Vernalis Group PLC is one of the few European biotechs to register a drug in the EU and the US. But delays in getting migraine treatment frovatriptan to an already crowded market mean the project has cost more than it's likely to recoup in the near term.